FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296162977> ?p ?o ?g. }

• W4296162977 abstract "The optimal dose of glucocorticoids for acute respiratory distress syndrome (ARDS) is uncertain. This study aimed to evaluate the effects of different doses of methylprednisolone on sepsis-induced acute lung injury (ALI) rats and a cohort of moderate and severe ARDS patients.ALI rats, challenged with lipopolysaccharide, were randomly received intraperitoneal injection of normal saline (model group) and different doses of methylprednisolone (0.5, 2, 8 mg/kg, named as low-, moderate- and high-dose group, respectively) for 5 days. The body weight changes of rats, inflammatory factors in bronchoalveolar lavage fluid (BALF), lung wet/dry ratio, histopathological score, and the mRNA expressions of glucocorticoid receptor α (GRα), GRβ and nuclear factor-κB (NF-κB) were measured. Forty moderate and severe ARDS patients were treated with standard of care or plus different doses of methylprednisolone (40, 80, 120 mg/day, named as low-, moderate- and high-dose group, respectively) for 5 days. Clinical outcomes were PaO2/FiO2 ratio and C-reactive protein (CRP) level at day 5, intubation rate, hospital stay, 28-day mortality, and adverse events rate.In animal experiment, different doses of methylprednisolone could increase the body weight of rats, and reduce inflammatory factors in BALF and the degree of lung injury compared with model group. The efficacy of methylprednisolone at moderate-dose was better than that at low-dose, but was equivalent to that at high-dose, which was consistent with the differential changes in the mRNA expression of GRα, GRβ and NF-κB. In clinical study, the moderate-dose group was associated with higher PaO2/FiO2 ratio and lower CRP level. No significant difference in other clinical outcomes among groups was detected.This study showed that the efficacy of methylprednisolone in ARDS treatment was not always dose-dependent due to the differential regulation of related receptors. The moderate-dose of methylprednisolone may be the potential optimal dose for ARDS treatment, which needs to be further verified by larger clinical trials." @default.
• W4296162977 created "2022-09-18" @default.
• W4296162977 creator A5023818066 @default.
• W4296162977 creator A5032831459 @default.
• W4296162977 creator A5033825187 @default.
• W4296162977 creator A5064705458 @default.
• W4296162977 creator A5065963467 @default.
• W4296162977 creator A5085432548 @default.
• W4296162977 date "2022-09-16" @default.
• W4296162977 modified "2023-10-09" @default.
• W4296162977 title "Effects of different doses of methylprednisolone therapy on acute respiratory distress syndrome: results from animal and clinical studies" @default.
• W4296162977 cites W1803784511 @default.
• W4296162977 cites W1964265808 @default.
• W4296162977 cites W1971696195 @default.
• W4296162977 cites W1971905187 @default.
• W4296162977 cites W1980224211 @default.
• W4296162977 cites W1982386968 @default.
• W4296162977 cites W1988948608 @default.
• W4296162977 cites W1990819855 @default.
• W4296162977 cites W1991241272 @default.
• W4296162977 cites W2026160182 @default.
• W4296162977 cites W2054683023 @default.
• W4296162977 cites W2056141899 @default.
• W4296162977 cites W2060037483 @default.
• W4296162977 cites W2064718903 @default.
• W4296162977 cites W2065631733 @default.
• W4296162977 cites W2074550595 @default.
• W4296162977 cites W2100541061 @default.
• W4296162977 cites W2106024919 @default.
• W4296162977 cites W2159912211 @default.
• W4296162977 cites W2286228001 @default.
• W4296162977 cites W2530180760 @default.
• W4296162977 cites W2590588347 @default.
• W4296162977 cites W2620241325 @default.
• W4296162977 cites W2793184777 @default.
• W4296162977 cites W2797626326 @default.
• W4296162977 cites W2925372427 @default.
• W4296162977 cites W2982312523 @default.
• W4296162977 cites W2982396267 @default.
• W4296162977 cites W3004626187 @default.
• W4296162977 cites W3092211520 @default.
• W4296162977 cites W3097806887 @default.
• W4296162977 cites W3133018554 @default.
• W4296162977 cites W3134253980 @default.
• W4296162977 cites W3154855659 @default.
• W4296162977 cites W3180328126 @default.
• W4296162977 cites W3199163281 @default.
• W4296162977 cites W4210627221 @default.
• W4296162977 cites W4211250103 @default.
• W4296162977 cites W4250658292 @default.
• W4296162977 cites W66687513 @default.
• W4296162977 cites W3129519311 @default.
• W4296162977 doi "https://doi.org/10.1186/s12890-022-02148-y" @default.
• W4296162977 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36114531" @default.
• W4296162977 hasPublicationYear "2022" @default.
• W4296162977 type Work @default.
• W4296162977 citedByCount "1" @default.
• W4296162977 countsByYear W42961629772023 @default.
• W4296162977 crossrefType "journal-article" @default.
• W4296162977 hasAuthorship W4296162977A5023818066 @default.
• W4296162977 hasAuthorship W4296162977A5032831459 @default.
• W4296162977 hasAuthorship W4296162977A5033825187 @default.
• W4296162977 hasAuthorship W4296162977A5064705458 @default.
• W4296162977 hasAuthorship W4296162977A5065963467 @default.
• W4296162977 hasAuthorship W4296162977A5085432548 @default.
• W4296162977 hasBestOaLocation W42961629771 @default.
• W4296162977 hasConcept C126322002 @default.
• W4296162977 hasConcept C141983124 @default.
• W4296162977 hasConcept C197934379 @default.
• W4296162977 hasConcept C2776348555 @default.
• W4296162977 hasConcept C2776804153 @default.
• W4296162977 hasConcept C2777714996 @default.
• W4296162977 hasConcept C2777961210 @default.
• W4296162977 hasConcept C2780372218 @default.
• W4296162977 hasConcept C42219234 @default.
• W4296162977 hasConcept C71924100 @default.
• W4296162977 hasConcept C90924648 @default.
• W4296162977 hasConceptScore W4296162977C126322002 @default.
• W4296162977 hasConceptScore W4296162977C141983124 @default.
• W4296162977 hasConceptScore W4296162977C197934379 @default.
• W4296162977 hasConceptScore W4296162977C2776348555 @default.
• W4296162977 hasConceptScore W4296162977C2776804153 @default.
• W4296162977 hasConceptScore W4296162977C2777714996 @default.
• W4296162977 hasConceptScore W4296162977C2777961210 @default.
• W4296162977 hasConceptScore W4296162977C2780372218 @default.
• W4296162977 hasConceptScore W4296162977C42219234 @default.
• W4296162977 hasConceptScore W4296162977C71924100 @default.
• W4296162977 hasConceptScore W4296162977C90924648 @default.
• W4296162977 hasIssue "1" @default.
• W4296162977 hasLocation W42961629771 @default.
• W4296162977 hasLocation W42961629772 @default.
• W4296162977 hasLocation W42961629773 @default.
• W4296162977 hasLocation W42961629774 @default.
• W4296162977 hasOpenAccess W4296162977 @default.
• W4296162977 hasPrimaryLocation W42961629771 @default.
• W4296162977 hasRelatedWork W1778338760 @default.
• W4296162977 hasRelatedWork W1974164973 @default.
• W4296162977 hasRelatedWork W2078283212 @default.
• W4296162977 hasRelatedWork W2084606304 @default.
• W4296162977 hasRelatedWork W2176723584 @default.

• next